Assistant Attending
Memorial Sloan Kettering Cancer Center
I am currently an Assistant Attending at Memorial Sloan Kettering Cancer Center (MSK), dedicated to advancing the field of oncology through innovative clinical trials and translational research. My research focuses on translating insights from the laboratory into early-phase clinical trials that can meaningfully improve patient outcomes. I plan to build upon my ongoing work by expanding my research program in two major areas: Targeted therapeutics for sarcomas and immunotherapy development. I am leading clinical and translational efforts to define mechanisms of resistance to CDK4/6 inhibition in DDLPS. I aim to build a portfolio of investigator-initiated trials targeting cell cycle alterations and MAPK pathway dependencies in sarcomas. My research also focuses on novel combination immunotherapy strategies for traditionally immune-resistant sarcomas. This includes leveraging transcriptomic and tumor microenvironment analyses to guide biomarker-driven clinical trial design.
